Cell and Gene Therapy

CLEVELAND, Ohio — September 18, 2026 Abeona Therapeutics congratulated Ultragenyx Pharmaceutical on the U.S. FDA approval of FAYUVI™ (rebisufligene...

Pleasanton, California, U.S., September 21, 2026 Veeva Systems has introduced Veeva Falcon Router, an agentic artificial intelligence solution designed...

Germantown, Maryland, U.S., September 21, 2026 Precigen has announced that the U.S. Food and Drug Administration (FDA) has granted...

Columbus, Ohio, September 18, 2026 Andelyn Biosciences has announced a major milestone in commercial gene therapy manufacturing following the...

Cambridge, UK, September 8, 2026 AstraZeneca has reported detailed results from the Phase III OBERON and TITANIA trials showing...

Waltham, Massachusetts, USA, September 8, 2026 NanoMosaic has joined a Mass General Brigham-led consortium selected for the Advanced Research...

Bailly-Romainvilliers, France — September 3, 2026 Resonant Clinical Solutions announced the acquisition of Creapharm Bioservices from Myonex, strengthening its...

Yantai, China — September 7, 2026 CelluPro, Ltd. announced that it has received EXCiPACT™ GMP Certification for Pharmaceutical Auxiliary...

AUSTIN, Texas, August 18, 2026 Genprex, Inc. has entered into a development and manufacturing agreement with a leading U.S.-based...

ST. PAUL, Minnesota, August 11, 2026 Egg Medical, Inc., a medical technology company focused on radiation protection for healthcare...